Hitesh Handa

Hitesh Handa

Auto-generated profile, based on publicly available information

Hitesh Handa

University of Georgia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Acta Biomaterialia
Verified
Journal Article
Closed access
PSPriyadarshini Singha
Priyadarshini Singha
JLJason Locklin
Jason Locklin
HHHitesh Handa
Hitesh Handa

14 April 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JPJitendra Pant
Jitendra Pant
MGMarcus J. Goudie
Marcus J. Goudie
SHSean P. Hopkins
Sean P. Hopkins
EBElizabeth J. Brisbois
Elizabeth J. Brisbois
HHHitesh Handa
Hitesh Handa

17 June 2022 in Progress in Materials Science
Verified
Journal Article
Closed access
MDMegan Douglass
Megan Douglass
MGMark Garren
Mark Garren
RDRyan Devine
Ryan Devine
AMArnab Mondal
Arnab Mondal
HHHitesh Handa
Hitesh Handa

19 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMarcus J. Goudie
Marcus J. Goudie
JPJitendra Pant
Jitendra Pant
HHHitesh Handa
Hitesh Handa
Recent reports on liquid-infused materials have shown promise in creating ultra-low fouling surfaces, but are limited in their ability to prevent bacterial proliferation and prevent platelet activation in blood-contacting applications. In this work, a liquid-infused nitric oxide-releasing (LINORel) material is created by incorporating the nitric oxide (NO) donorS-nitroso-acetylpenicillamine (SNAP) and silicone oil in commercial medical grade silicone rubber tubing through a solvent swelling process. This combination provides several key advantages over previous NO-releasing materials, including decreased leaching of NO donor, controlled release of NO, and maintenance of ultra-low fouling property of liquid-infused materials. The LINORel tubing reduces protein adhesion as observed using fluorescence imaging, and platelet adhesion (81.7 ± 2.5%)in vitroover a 2 h period. The LINORel combination greatly reduces bacterial adhesion and biofilm formation of two most common pathogens responsible for hospital acquired infections: gram-positiveStaphylococcus aureusand gram-negativePseudomonas aeruginosa(99.3 ± 1.9% and 88.5 ± 3.3% respectively) over a 7-day period in a CDC bioreactor environment. Overall, the LINORel approach provides a synergistic combination of active and passive non-fouling approaches to increase biocompatibility and reduce infection associated with medical devices.

9 December 2021 in Materials Today Chemistry
Verified
Journal Article
Closed access
SGS. Ghalei
S. Ghalei
HHH. Handa
H. Handa

12 January 2015 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
EBElizabeth J. Brisbois
Elizabeth J. Brisbois
RDRyan P. Davis
Ryan P. Davis
AJAnna M. Jones
Anna M. Jones
TMTerry C. Major
Terry C. Major
RBRobert H. Bartlett
Robert H. Bartlett
HHHitesh Handa
Hitesh Handa
Thrombosis and infection are two common problems associated with blood-contacting medical devices such as catheters. Nitric oxide (NO) is known to be a potent antimicrobial agent as well as an inhibitor of platelet activation and adhesion. Healthy endothelial cells that line the inner walls of all blood vessels exhibit a NO flux of 0.5–4 × 10−10 mol cm−2 min−1 that helps prevent thrombosis. Materials with a NO flux that is equivalent to this level are expected to exhibit similar anti-thrombotic properties. In this study, NO-releasing catheters were fabricated by incorporating S-nitroso-N-acetylpenicillamine (SNAP) in the Elast-eon E2As polymer. The SNAP/E2As catheters release physiological levels of NO for up to 20 days, as measured by chemiluminescence. Furthermore, SNAP is stable in the E2As polymer, retaining 89% of the initial SNAP after ethylene oxide (EO) sterilization. The SNAP/E2As and E2As control catheters were implanted in sheep veins for 7 days to examine the effect on thrombosis and bacterial adhesion. The SNAP/E2As catheters reduced the thrombus area when compared to the control (1.56 ± 0.76 and 5.06 ± 1.44 cm2, respectively). A 90% reduction in bacterial adhesion was also observed for the SNAP/E2As catheters as compared to the controls. The results suggest that the SNAP/E2As polymer has the potential to improve the hemocompatibility and bactericidal activity of intravascular catheters, as well as other blood-contacting medical devices (e.g., vascular grafts, extracorporeal circuits).